Explore 3 Stock Ideas & Industry Insights Download Free Report

Cannabis Global Inc

Healthcare US CBGL

0.0001USD
0.00(0%)

Last update at 2026-06-19T20:00:00Z

Day Range

0.00010.0001
LowHigh

52 Week Range

-0.0002
LowHigh

Fundamentals

  • Previous Close 0.0001
  • Market Cap0.66M
  • Volume1900000
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.31866M
  • Revenue TTM1.06M
  • Revenue Per Share TTM0.003
  • Gross Profit TTM -0.11544M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-08-31 2024-08-31 2023-08-31 2022-08-31 2021-08-31
Type yearly yearly yearly yearly yearly
Date 2025-08-31 2024-08-31 2023-08-31 2022-08-31 2021-08-31
Income before tax -0.26470M -0.35800M -1.08400M - -8.11598M
Minority interest - - - - 0.28M
Net income -0.26470M -0.35800M -1.04100M - -15.06245M
Selling general administrative - - - - 2.06M
Selling and marketing expenses - - - - 0.06M
Gross profit - - 0.08M - 0.18M
Reconciled depreciation - - - - 0.08M
Ebit - - 0.34M -2.58656M -1.94392M
Ebitda -0.02994M -0.13800M 0.37M - -2.06939M
Depreciation and amortization - - 0.03M - -0.12546M
Non operating income net other - - - - -
Operating income -0.02994M -0.13800M -0.34600M - -1.94392M
Other operating expenses 0.03M 0.14M 0.59M - 3.54M
Interest expense 0.23M 0.22M 1.42M - 7.44M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -7.43734M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -0.35800M -0.04279M - 6.95M
Total revenue - - 0.24M - 1.60M
Total operating expenses 0.03M 0.14M 0.42M - 2.13M
Cost of revenue - - 0.16M - 1.42M
Total other income expense net -0.23475M -0.22000M -0.73800M - -6.17206M
Discontinued operations - - - - -
Net income from continuing ops - - - - -8.11598M
Net income applicable to common shares - - - -13.84962M -7.83484M
Preferred stock and other adjustments - - - - -
Breakdown 2025-08-31 2024-08-31 2023-08-31 2022-08-31 2021-08-31
Type yearly yearly yearly yearly yearly
Date 2025-08-31 2024-08-31 2023-08-31 2022-08-31 2021-08-31
Total assets 0.89M 0.89M 0.89M - 11.34M
Intangible assets - - - - 0.50M
Earning assets - - - - -
Other current assets - - - 0.02M 0.00799M
Total liab 6.18M 6.23M 5.91M - 9.98M
Total stockholder equity -4.77182M -4.77546M -4.45274M - -2.21234M
Deferred long term liab - - - - -
Other current liab 1.34M 1.27M 1.04M 1.23M 4.90M
Common stock 0.07M 4.32M 1.46M 0.73M 0.08M
Capital stock - - - - 0.09M
Retained earnings -27.03957M -26.86467M -26.01714M -24.97620M -13.89179M
Other liab - - - - -
Good will - - - - 8.84M
Other assets - - - 0.00720M 0.05M
Cash 0.01M 0.01M 0.01M - 0.03M
Cash and equivalents - - - - -
Total current liabilities 5.27M 5.32M 5.00M 5.35M 8.75M
Current deferred revenue - - - - 0.35M
Net debt 3.82M 3.50M 3.92M - 3.98M
Short term debt 2.92M 3.08M 3.02M - 2.77M
Short long term debt - - - - 2.70M
Short long term debt total 3.83M 3.99M 3.93M - 4.01M
Other stockholder equity 22.20M 17.77M 20.10M 0.00208M 11.59M
Property plant equipment - - - 0.65M 0.85M
Total current assets 0.26M 0.26M 0.26M 1.07M 0.44M
Long term investments - - - - 0.65M
Net tangible assets - - - -4.13500M -11.55591M
Short term investments - - - - -
Net receivables 0.05M 0.05M 0.05M 0.22M 0.21M
Long term debt - - - - 0.67M
Inventory 0.20M 0.20M 0.20M 0.35M 0.19M
Accounts payable 1.00M 0.97M 0.93M 1.05M 0.73M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.00208M 0.00208M 0.00208M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.00720M 0.00720M 0.00720M - 0.05M
Deferred long term asset charges - - - - -
Non current assets total 0.62M 0.62M 0.62M - 10.90M
Capital lease obligations - - - - 0.63M
Long term debt total - - - - -
Breakdown 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Type yearly yearly yearly yearly yearly
Date 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Investments - - 0.41M -0.00731M -0.01550M
Change to liabilities - - 0.37M 0.12M -0.08739M
Total cashflows from investing activities - - 0.40M -0.00731M -0.01550M
Net borrowings - - 0.64M 1.00M 0.67M
Total cash from financing activities 0.07M 0.02M 0.64M 1.51M 1.39M
Change to operating activities - - 0.35M 0.29M 0.03M
Net income -0.35776M -1.04095M -13.84962M -8.11598M -4.92935M
Change in cash - -0.07394M 0.05M 0.03M -0.14974M
Begin period cash flow 0.01M 0.09M 0.03M 0.00234M 0.15M
End period cash flow 0.01M 0.01M - 0.03M 0.00234M
Total cash from operating activities -0.06509M -0.09822M -0.98387M -1.47105M -1.52214M
Issuance of capital stock - - - 0.51M 0.71M
Depreciation - 0.03M 1.34M 0.08M 0.00334M
Other cashflows from investing activities - -0.00000M - - -
Dividends paid - - - - -
Change to inventory - 0.15M -0.15887M -0.11374M -0.07304M
Change to account receivables - 0.17M -0.10383M 0.08M 0.08M
Sale purchase of stock - - - - -
Other cashflows from financing activities 0.07M - - 2.14M 0.67M
Change to netincome - - 11.07M 5.90M 3.53M
Capital expenditures 0.00000M 0.00000M 0.00451M 0.00951M 0.02M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.07M 0.81M - 0.38M -0.12713M
Stock based compensation - - - 0.59M 2.35M
Other non cash items 0.22M 0.11M - 7.31M 1.34M
Free cash flow -0.06509M -0.09822M - -1.48056M -1.53764M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CBGL
Cannabis Global Inc
- -% 0.0001 - - 0.62 0.07 1.60 1.62
ZTS
Zoetis Inc
-2.82 3.58% 75.89 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR
-0.19 0.62% 30.56 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
- -% 157.12 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG
- -% 42.94 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

Profile

Cannabis Global, Inc. focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body. The company offers cannabis flower packaged, pre-rolls, and edible products to cannabis retailers and distributors; and Comply Bag, a solution for cannabis storage, transport, and tracking. It also provides managerial services in areas of the regulated hemp and cannabis industries. The company was formerly known as MCTC Holdings, Inc. and changed its name to Cannabis Global, Inc. in December 2019. Cannabis Global, Inc. was incorporated in 2005 and is headquartered in Los Angeles, California.

Cannabis Global Inc

520 South Grand Avenue, Los Angeles, CA, United States, 90071

Key Executives

Name Title Year Born
Mr. Edward Manolos Chairman, CEO, CFO, Principal Accounting Officer, Pres, Sec. & Treasurer 1975
Mr. Edward Manolos Chairman, CEO, CFO, Principal Accounting Officer, President, Secretary & Treasurer 1975

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.